Food and Drug Administration

Allergenic Products Advisory Committee

March 15, 2002

Slides

COMMITTEE UPDATES (Open Session)

Overview of the Division of Bacterial, Parasitic & Allergenic Products (DBPAP), Richard Walker, Ph.D., Division Director, FDA  ppt   htm

Overview of the Laboratory of Immunobiochemistry:  Personnel, organizational, and lot release activities, Jay E. Slater, M.D., DBPAP, Laboratory Chief, FDA    ppt   htm

LIB Site Visit, January 24, 2002, Jay E. Slater, M.D., DBPAP, Laboratory Chief, FDA, Ronald Rabin, M.D., DBPAP, FDA   ppt   htm

Particulates in Allergen Extracts and Compliance Overview,  Jay E. Slater, M.D., FDA   ppt   htm

Compliance Update, Teddi Lopez, OCBQ, FDA  ppt   htm

   Reduction of Possible Exposure to TSE Agents in Allergen Extracts, Jay E. Slater, M.D., FDA   ppt   htm

Open Public Hearing

REGULATORY DISCUSSION TOPICS (Open Session)

Considerations for the Regulation of Recombinant Allergens for the Diagnosis and Treatment of Allergic Disease, Jay E. Slater, M.D., FDA   ppt   htm

Glycerol in Allergen Extracts, Jay E. Slater, M.D., FDA  ppt   htm